Intradermal vaccination

Efficient and user-friendly vaccination method


Intradermal (ID) vaccination without the use of needles is the newest technology developed within vaccination equipment for pigs. The technology excel in giving a consistent dose of 0.2 ml in the skin of the pig. The injection is performed using compressed air with a pressure of 46 bar, basically without the pig noticing it. Additionally, the method offers flexibility in the choice of vaccination site. Since the vaccination is not related to pain, the vaccination and stress handling are significantly reduced. This means increased welfare for both the animals and the caretaker. The freedom from needles also means no risk of broken needles or injection injuries to the muscle tissue. Food safety is hereby increased and the risk of damaging valuable meat is avoided.

Benefits for the pig

• Small injection volume (0.2 ml)

• Less pain1 - improved animal welfare

• No risk of broken needles

• No damage to the muscle tissue

• Immune response comparable to traditional intramuscular vaccination1

• Reduced risk of disease transmission between pigs2

Benefit for the user

• User friendly1

• High flexibility in the choice of vaccination area3

• Vaccination requires minimal physical effort1,4

• High-performance battery - gives more than 1200 doses per IDAL 3G battery charge

• High number of pigs can be vaccinated in a shorter period of time

Immune response induced by intradermal vaccination


Vaccine deposit

By intradermal vaccination, the vaccine is deposited in the pig’s dermis.


Comparable immune response

Studies have shown similar immune responses following intradermal and intramuscular administrations of vaccine1

1) Ferrari L. et al. (2011). Evaluation of the immune response induced by intradermal vaccination by using a needleless system in comparison with the intramuscular route in conventional pigs. Research in Veterinary Science 90 64-71.

2) Baker, S. R et. al. (2012). Evaluation of a needle-free injection device to prevent hematogenous transmission of porcine reproductive and respiratory syndrome virus. Journal of Swine Health and Production. Vol. 20. No. 3. 123-128.

3) Bekendtgørelse nr. 780 af 24/06/201 §8 – Bekendtgørelse om dyreejers anvendelser af lægemidler til dyr samt offentlig egenkontrol med restkoncentrationer.

4) Tassis, P.D. et al. (2012). Clinical evaluation of intradermal vaccination against porcine inzootic pneumonia (Mycoplasma Hyopneumoniae). Veterinary Record, published online doi: 10.1136/vr. 100239

MSD Animal Health

Havneholmen 25

1561 København V

Phone: +45 4482 4200

E-mail: info@idal.dk

Technical responsible:

Bjarne Ellegaard: +45 2325 3443

Mia Qvist Pawlowski: +45 3070 6201

Annette Bech: +45 2459 7747

Opening hours:

Monday - Friday: 8:00 AM - 16:00 PM